Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis

Clinical trial NCT06723405 · COMPLETED

Trial details

NCT number: NCT06723405
Sponsor: Evommune, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis (AD)Eczema Eczema Atopic Dermatitis

Start date: 2025-02-13
Primary completion: 2025-11-17
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.